Italy delays controversial registration rules
This article was originally published in SRA
Italian medical device manufacturers and distributors have been granted a four-month extension - until 30 April 2009 - to re-register their products that were already on the market when controversial and complex new registration requirements entered into force in May 20071,2. Vibha Sharma reports.
You may also be interested in...
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
Existing importers and manufacturers of certain medical devices can continue marketing their products for six months or until the Indian medtech regulator makes a final decision on their pending licensing applications.
Differences between how Australia and the EU define “central circulatory system” has resulted in different risk classification levels being assigned to some devices in the two jurisdictions.